Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CTT Pharmaceuticals

CTT Pharmaceuticals
2013 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
CTTH STOCK SYMBOL
$0.21 SHARE PRICE (As of Friday Closing)
Description

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The thin wafers are infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.

Formerly Known As
Mindesta
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Delivery
Drug Discovery
Stock Exchange
PINX
Primary Office
  • 35 Galbraith Drive
  • Stoney Creek, Ontario L8G 1Z7
  • Canada

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CTT Pharmaceuticals’s full profile, request a free trial.

CTT Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.15 - $0.80 $0.24 39.7K

CTT Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2016
FY 2015
31-Dec-2015
FY 2014
31-Dec-2014
FY 2013
31-Dec-2013
Enterprise Value 807 309 9,001 51
Revenue 0 0 0 0
EBITDA (1,056) (1,446) 228 (19)
Net Income (1,056) (1,446) 228 (19)
Total Assets 45 644 1,662 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CTT Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore CTT Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

CTT Pharmaceuticals Executive Team (4)

Name Title Board
Seat
Contact
Info
Pankaj Modi Ph.D President, Chief Executive Officer & Chief Scientific Officer
Dean Hanisch Treasurer, Director & Secretary
Gregory Bowes Chief Executive Officer & Chief Financial Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »